Literature DB >> 4138703

Restoration of immune competence in tolerant mice by parabiosis to normal mice.

S Zolla, D Naor.   

Abstract

These studies demonstrate that mice tolerant to human gamma globulin (HGG) regain their ability to make antibody to HGG after parabiosis to normal mice. This can be demonstrated by enumeration of PFC in the spleens of both the normal and tolerant partners. Hemagglutinin titers of normal-tolerant parabionts, however, are exceptionally low; serum antibody appears to be neutralized by circulating HGG present originally in the serum of the tolerant partner. These data support the hypothesis that tolerance to HGG in mice is a "defective" state due to the absence of cells capable of responding to this antigen.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4138703      PMCID: PMC2139713          DOI: 10.1084/jem.140.5.1421

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  10 in total

1.  Genetic factors in parabiosis.

Authors:  E J EICHWALD; E C LUSTGRAAF; M STRAINER
Journal:  J Natl Cancer Inst       Date:  1959-12       Impact factor: 13.506

2.  Tolerance of F1 hybrid skin homografts in the parent strain induced by parabiosis.

Authors:  C MARTINEZ; F SHAPIRO; H KELMAN; T ONSTAD; R A GOOD
Journal:  Proc Soc Exp Biol Med       Date:  1960-02

3.  Attempts to demonstrate an in vivo role for serum blocking factors in tolerant mice.

Authors:  L Brent; C Brooks; N Lubling; A V Thomas
Journal:  Transplantation       Date:  1972-09       Impact factor: 4.939

4.  Immunosuppressive effect of serum from CBA mice made tolerant by the subernatant from ultracentrifuged bovine gamma globulin.

Authors:  J L Tong; D Boose
Journal:  J Immunol       Date:  1970-08       Impact factor: 5.422

5.  A modification of the hemolytic plaque assay for use with protein antigens.

Authors:  E S Golub; R I Mishell; W O Weigle; R W Dutton
Journal:  J Immunol       Date:  1968-01       Impact factor: 5.422

6.  Studies on the induction of immunologic unresponsiveness. 3. Antigen form and mouse strain variation.

Authors:  E S Golub; W O Weigle
Journal:  J Immunol       Date:  1969-02       Impact factor: 5.422

7.  Glutaraldehyde, cyanuric chloride and tetrazotized O-dianisidine as coupling reagents in the passive hemagglutination test.

Authors:  S Avrameas; B Taudou; S Chuilon
Journal:  Immunochemistry       Date:  1969-01

8.  Binding of 125I-BSA to lymphoid cells of tolerant mice.

Authors:  D Naor; D Sulitzeanu
Journal:  Int Arch Allergy Appl Immunol       Date:  1969

9.  Termination of tolerance to human gamma globulin in mice by antigen and bacterial lipopolysaccharide (endotoxin).

Authors:  J M Chiller; W O Weigle
Journal:  J Exp Med       Date:  1973-03-01       Impact factor: 14.307

10.  The abrogation of sheep erythrocyte tolerance in rats by means of the transfer of allogeneic lymphocytes.

Authors:  P J McCullagh
Journal:  J Exp Med       Date:  1970-11       Impact factor: 14.307

  10 in total
  5 in total

1.  Cellular basis of persistent tolerance induced by an aggregate free heterologous immunoglobulin.

Authors:  C J Elson; R B Taylor
Journal:  Immunology       Date:  1977-11       Impact factor: 7.397

Review 2.  Current perspectives on the cellular mechanisms of immunologic tolerance.

Authors:  D E Parks; W O Weigle
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

3.  Tolerance induction during ontogeny. I. Presence of active suppression in mice rendered tolerant to human gamma-globulin in utero correlates with the breakdown of the tolerant state.

Authors:  C A Waters; L M Pilarski; T G Wegmann; E Diener
Journal:  J Exp Med       Date:  1979-05-01       Impact factor: 14.307

4.  Induction and mode of action of suppressor cells generated against human gamma globulin. II. Effects of colchicine.

Authors:  D E Parks; D A Shaller; W O Weigle
Journal:  J Exp Med       Date:  1979-05-01       Impact factor: 14.307

5.  Induction and mode of action of suppressor cells generated against human gamma globulin. I. An immunologic unresponsive state devoid of demonstrable suppressor cells.

Authors:  D E Parks; M V Doyle; W O Weigle
Journal:  J Exp Med       Date:  1978-09-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.